BWP
Baldwin Wealth Partners Portfolio holdings
AUM
$1.47B
This Quarter Return
+8.19%
1 Year Return
+14.5%
3 Year Return
+75.05%
5 Year Return
+119.99%
10 Year Return
+341.18%
AUM
$1.1B
AUM Growth
+$1.1B
(+52%)
Cap. Flow
+$349M
Cap. Flow
% of AUM
31.68%
Top 10 Holdings %
Top 10 Hldgs %
29.13%
Holding
845
New
171
Increased
210
Reduced
101
Closed
65
Top Buys
| 1 |
Exxon Mobil
XOM
|
$16.6M |
| 2 |
Analog Devices
ADI
|
$12.7M |
| 3 |
Vanguard Small-Cap Value ETF
VBR
|
$12.4M |
| 4 |
Johnson & Johnson
JNJ
|
$12.3M |
| 5 |
Alerian MLP ETF
AMLP
|
$12M |
Top Sells
| 1 |
iShares TIPS Bond ETF
TIP
|
$5M |
| 2 |
Target
TGT
|
$3.62M |
| 3 |
Estee Lauder
EL
|
$2.81M |
| 4 |
Comcast
CMCSA
|
$1.04M |
| 5 |
Verizon
VZ
|
$879K |
Sector Composition
| 1 | Technology | 21.56% |
| 2 | Healthcare | 14.86% |
| 3 | Financials | 13.17% |
| 4 | Consumer Staples | 9.34% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Marriott International Class A Common Stock
MAR
$72B
| $7.01M | 0.64% |
47,105
+7,711
| +20% | +$1.15M |
|
52
iShares Core S&P 500 ETF
IVV
$660B
| $6.83M | 0.62% |
17,786
+519
| +3% | +$199K |
|
53
Enterprise Products Partners
EPD
$68.9B
| $6.58M | 0.6% |
272,707
+19,430
| +8% | +$469K |
|
54
Dover
DOV
$24B
| $6.52M | 0.59% |
48,126
+48,036
| +53,373% | +$6.5M |
|
55
Vanguard Total Bond Market
BND
$133B
| $6.43M | 0.58% |
89,498
+62,629
| +233% | +$4.5M |
|
56
Bank of America
BAC
$371B
| $6M | 0.54% |
181,175
+18,137
| +11% | +$601K |
|
|
57
Target
TGT
$42B
| $5.89M | 0.53% |
39,550
-24,305
| -38% | -$3.62M |
|
58
Paychex
PAYX
$48.8B
| $5.77M | 0.52% |
49,916
+49,241
| +7,295% | +$5.69M |
|
59
Berkshire Hathaway Class B
BRK.B
$1.08T
| $5.44M | 0.49% |
17,595
+9,711
| +123% | +$3M |
|
60
CF Industries
CF
$13.7B
| $5.43M | 0.49% |
63,705
+92
| +0.1% | +$7.84K |
|
61
MSCI
MSCI
$42.7B
| $5.36M | 0.49% |
11,514
-365
| -3% | -$170K |
|
62
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
$6.25B
| $5.11M | 0.46% |
51,293
-7,549
| -13% | -$753K |
|
63
Novartis
NVS
$248B
| $4.76M | 0.43% |
52,508
+50,894
| +3,153% | +$4.62M |
|
64
Thermo Fisher Scientific
TMO
$183B
| $4.58M | 0.42% |
8,323
+4,095
| +97% | +$2.26M |
|
65
PayPal
PYPL
$66.5B
| $4.31M | 0.39% |
60,470
+47,866
| +380% | +$3.41M |
|
66
Altria Group
MO
$112B
| $4.3M | 0.39% |
94,010
+84,910
| +933% | +$3.88M |
|
67
Philip Morris
PM
$254B
| $4.06M | 0.37% |
40,073
+34,802
| +660% | +$3.52M |
|
68
Roper Technologies
ROP
$56.4B
| $4.06M | 0.37% |
9,386
+6,097
| +185% | +$2.63M |
|
69
Stock Yards Bancorp
SYBT
$2.34B
| $4.02M | 0.36% |
+61,848
| New | +$4.02M |
|
70
Automatic Data Processing
ADP
$121B
| $3.92M | 0.36% |
16,430
+15,450
| +1,577% | +$3.69M |
|
71
Pfizer
PFE
$141B
| $3.91M | 0.35% |
76,220
+29,308
| +62% | +$1.5M |
|
72
McCormick & Company Non-Voting
MKC
$18.7B
| $3.85M | 0.35% |
46,477
+42,734
| +1,142% | +$3.54M |
|
73
Toronto Dominion Bank
TD
$128B
| $3.74M | 0.34% |
57,730
+43,504
| +306% | +$2.82M |
|
74
Novo Nordisk
NVO
$252B
| $3.69M | 0.33% |
27,250
+24,531
| +902% | +$3.32M |
|
75
Axsome Therapeutics
AXSM
$6.09B
| $3.66M | 0.33% |
47,495
-5,350
| -10% | -$413K |
|